{"schema":"sb.node.v1","id":"sb:e/5a7826d4b7c4b767cc40bab8","kind":"entity","label":{"text":"sanofi","locale":"en"},"identity":{"anchor":"label:en:sanofi","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-09T23:33:39.923351+00:00","snapshot":"deploy 7f093f1d72c3a2c641cd5e765e3c056469e8e4f6"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":72,"separatePublishers":37,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":1,"named":9,"of":9,"basis":"receipts the entity graph keeps whose own headline names the subject, over all receipts it keeps for the subject (the door's measurement; the graph carries none of its own). Only the former are served"}},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-08-24","to":"2026-10-08","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.194: about 81% of mentions carry no typed assertion"]}},"dimensions":{"domains":["auto","biotech_pharma","fda_decisions"],"activeDays":25,"assertions":{}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":9,"byKind":{"observation":9},"withheld":{"state":"withheld","count":3,"reason":"3 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/0dd2f5f4fbe49e92d4449332","kind":"observation","label":"Fierce Pharma · 2026-10-07 · Sanofi drafts NY Knicks star Karl-Anthony Towns for COVID, Nuvaxovid awareness push","url":"https://www.fiercepharma.com/marketing/sanofi-drafts-ny-knicks-star-karl-anthony-towns-covid-nuvaxovid-awareness-push"},{"id":"sb:o/0566e313c0d683a028bbb5f6","kind":"observation","label":"Endpoints News · 2026-10-03 · Eli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more","url":"https://endpoints.news/eli-lillys-best-ever-weight-loss-data-sanofi-regeneron-re-up-for-1b-upfront-and-more/"},{"id":"sb:o/aae8c22208f982202bc21a76","kind":"observation","label":"BioPharma Dive · 2026-10-02 · Sanofi, Regeneron broaden alliance to find their next Dupixent","url":"https://www.biopharmadive.com/news/sanofi-regeneron-alliance-expanded-dupixent-immunology-drugs-development/831894/"},{"id":"sb:o/1bb7e1651b3a27edd8ec3373","kind":"observation","label":"Endpoints News · 2026-10-01 · Sanofi builds on immunology alliance with Regeneron for $1B upfront","url":"https://endpoints.news/sanofi-builds-on-immunology-alliance-with-regeneron-for-1b-upfront/"},{"id":"sb:o/b807be493d1ddf778e00eb31","kind":"observation","label":"STAT News · 2026-10-01 · STAT+: Sanofi, Regeneron expand partnership after Dupixent success","url":"https://www.statnews.com/2026/10/01/sanofi-regeneron-agreement-dupixent-antibodies-immunology/?utm_campaign=rss"},{"id":"sb:o/9d49411f624a694aeb184e52","kind":"observation","label":"MarketBeat News Feed · 2026-09-22 · Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research Engine","url":"https://www.marketbeat.com/instant-alerts/event-sanofi-reviews-pipeline-broadens-deal-hunt-as-it-rebuilds-research-engine-2026-09-22/"},{"id":"sb:o/85feae787a38d598e3447b28","kind":"observation","label":"MarketBeat News Feed · 2026-09-20 · Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss","url":"https://www.marketbeat.com/instant-alerts/event-sanofi-eyes-25b-dupixent-future-expands-ma-hunt-ahead-of-patent-loss-2026-09-20/"},{"id":"sb:o/9b6518177a96f0c5fa3d5b2d","kind":"observation","label":"MarketBeat News Feed · 2026-09-19 · NewEdge Advisors LLC Trims Stock Position in Sanofi $SNY","url":"https://www.marketbeat.com/instant-alerts/filing-newedge-advisors-llc-trims-stock-position-in-sanofi-sny-2026-09-19/"},{"id":"sb:o/eea6eb9b682af770e44e502b","kind":"observation","label":"Fierce Pharma · 2026-09-18 · Bavarian Nordic secures Sanofi, AZ vet to fill shoes of longtime CEO Paul Chaplin","url":"https://www.fiercepharma.com/pharma/bavarian-nordic-secures-sanofi-az-vet-fill-shoes-longtime-ceo-paul-chaplin"}],"cursor":null,"order":"newest first; we keep the 9 newest receipts for this entity whose own headline names it. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with pfizer (26 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/1249a8a416f1a8445b8c5313"},{"kind":"relation","label":"co-mentioned with fda (24 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/e182c757a284f364dcb71fd9"},{"kind":"relation","label":"co-mentioned with astrazeneca (22 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/72003487d2212268ebbfdc61"},{"kind":"relation","label":"co-mentioned with novartis (21 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/b19816aee91127a1fd7ad805"},{"kind":"relation","label":"co-mentioned with regeneron (21 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/371222d473d4cc26ff82a2ce"},{"kind":"relation","label":"co-mentioned with eli lilly (20 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/ccab44b92b38ac49acd75f98"},{"kind":"relation","label":"co-mentioned with roche (18 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/3f1f9ba01a697520e58a3050"},{"kind":"relation","label":"co-mentioned with france (18 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/bae43b98bd665941d83bfe97"},{"kind":"relation","label":"co-mentioned with amgen (16 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/03840f48100ff31edc2b16d2"},{"kind":"relation","label":"co-mentioned with abbvie (14 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/dd6ce254addbe4ee7de27dbf"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/5a7826d4b7c4b767cc40bab8","mcp":"traverse {\"id\":\"sb:e/5a7826d4b7c4b767cc40bab8\"}","page":"/entity/sanofi/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5a7826d4b7c4b767cc40bab8\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5a7826d4b7c4b767cc40bab8\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5a7826d4b7c4b767cc40bab8\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/5a7826d4b7c4b767cc40bab8\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}